All news from Anaesthesiology

Rhopressa: FDA Approved New Glaucoma Drug

A 12-year-old Duke University spinoff founded by two Duke professors has received regulatory approval for its first drug: eleven-a-day eye drops for glaucoma patients.  Aerie Pharmaceuticals received approval for the medication, Rhopressa , from the Food and Drug Administration ( FDA )

Cerebellum Involved in Processing Traumatic Memories

When a person is diagnosed and treated for long-term potentially fatal diseases such as cancer, they often accumulate distressing and traumatic experiences along the way. A new study from the Marcus Institute of Integrative Health at Thomas Jefferson University reveals how Neuro Emotional Technique (NET) substantially alters the brain’s response to traumatic memories and reveals the potential importance of the cerebellum in regulating the brain and body’s response to traumatic stress.

Interrupted Reprogramming: Progenitor-like Cells produced

A modified version of iPS methodology, called interrupted reprogramming, allows for a highly controlled, potentially safer, and more cost-effective strategy for generating progenitor-like cells from adult cells. As demonstrated in the journal Stem Cell Reports, the adult mouse respiratory tract cells called Club cells into large, pure populations of induced progenitor-like (iPL) cells, which retained a residual memory of their parental cell lineage and therefore generated mature Club cells. These cells showed potential as a cell replacement therapy in mice with cystic fibrosis.

Cancer mortality: Decades-long drop

The cancer death rate dropped 1.7% from 2014 to 2015, continuing a drop that began in 1991 and has reached 26%, resulting in nearly 2.4 million fewer cancer deaths during that time. The data is reported in Cancer Statistics 2018, the American Cancer Society's comprehensive annual report on cancer incidence, mortality, and survival. It is published in CA: A Cancer Journal for Clinicians and is accompanied by its consumer version: Cancer Facts and Figures 2018.